Moderna shares surge after it says experimental mRNA cancer treatment passed key test

AI Summary

Moderna and Merck are developing a treatment using an mRNA-based cancer vaccine called intismeran that is designed to be tailored to individual patients based on unique mutations within their tumors. Newsiline summarises this report from PBS NewsHour Headlines and links readers to the original publisher for the full story.

Key Points

• Original report published by PBS NewsHour Headlines.
• Newsiline stores only headline metadata, source credit, and a short summary.
• Readers are directed to the publisher for the complete article.

Why It Matters

This story may affect readers following the category, country, or source involved. Newsiline keeps the summary neutral and points to the publisher for full context.